IntegriChain

IntegriChain builds a cloud-based data and analytics platform that helps pharmaceutical manufacturers manage market access. The platform aggregates data from wholesalers, specialty pharmacies, payers, and group purchasing organizations to support contract management, government pricing compliance, gross-to-net forecasting, and patient affordability analytics.

The company serves pharmaceutical and biotechnology manufacturers that need to commercialize and distribute drugs in the United States. These customers range from large, multinational pharma corporations to mid-size biotechs launching their first commercial products.

IntegriChain is purpose-built for life sciences market access and does not compete as a broad ERP or CRM platform. Its data model is designed to normalize data from the specific entities that touch pharmaceutical distribution — such as specialty pharmacies, 340B covered entities, and wholesalers — and its compliance modules address regulations unique to drug pricing, including Medicaid best price and the 340B Drug Pricing Program.

No. IntegriChain is privately held and does not disclose revenue, profitability, or ownership structure publicly.

Announced in May 2024, Government Pricing Cloud is a module that automates compliance with US federal drug pricing programs, including Medicaid rebate calculations and 340B ceiling price requirements. It is designed to reduce the manual effort and regulatory risk associated with filing pricing data with the Centers for Medicare & Medicaid Services (CMS).

IntegriChain's platform primarily handles commercial, financial, and distribution data rather than clinical trial or electronic health record data. Its patient-facing analytics are concentrated in affordability, copay assistance, and patient services program tracking rather than clinical outcomes.

The company benefits from high switching costs driven by regulatory embedding. Pharmaceutical manufacturers integrate IntegriChain into their monthly and quarterly government pricing filings, contract rebate accruals, and channel data feeds. Re-platforming these workflows requires significant validation, audit trail reconstruction, and regulatory recertification, which acts as a barrier to competitor displacement.